Kinnate Biopharma Inc.
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Kinnate Biopharma Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Kinnate Biopharma Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Kinnate Biopharma Inc..